These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13081041)

  • 21. Relation of poliomyelitis virus types to clinical disease and geographic distribution: a preliminary report.
    SHELOKOV A; HABEL K; MCKINSTRY DW
    Ann N Y Acad Sci; 1955 Sep; 61(4):998-1004. PubMed ID: 13340608
    [No Abstract]   [Full Text] [Related]  

  • 22. [Advances and perspectives in the epidemiology and immunologic prevention of poliomyelitis].
    GIOVANARDI A
    Boll Ist Sieroter Milan; 1954; 33(11-12):505-53. PubMed ID: 14363402
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis.
    Shen L; Chen CY; Huang D; Wang R; Zhang M; Qian L; Zhu Y; Zhang AZ; Yang E; Qaqish A; Chumakov K; Kouiavskaia D; Vignuzzi M; Nathanson N; Macadam AJ; Andino R; Kew O; Xu J; Chen ZW
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28356537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological epidemiology of poliomyelitis; distribution of immunity to poliomyelitis virus.
    FALLON RJ
    Lancet; 1956 Jan; 270(6907):65-9. PubMed ID: 13287058
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimates of the infection rates for poliomyelitis virus in the years preceding the poliomyelitis epidemics of 1916 in New York and 1945 on Mauritius.
    SAMPLE DW; EVANS CA
    J Hyg (Lond); 1957 Jun; 55(2):254-65. PubMed ID: 13439175
    [No Abstract]   [Full Text] [Related]  

  • 26. [USE OF HOMOTYPE ORAL ANTIPOLIOMYELITIC VACCINE DURING AN EPIDEMIC OCCURRING IN FRANCE AND DUE TO TYPE I POLIOMYELITIS VIRUS].
    DEBRE R; COULON G; LEDOURNEUF G; GAUTIER M; CELERS J; DROUHET V; BOUE A
    Bull Acad Natl Med; 1964 Feb 4-11; 148():75-86. PubMed ID: 14136499
    [No Abstract]   [Full Text] [Related]  

  • 27. [EPIDEMIOLOGICAL EVALUATION OF AN ATTENUATED STRAIN OF POLIOMYELITIS VIRUS (P712) USED FOR MASS VACCINATION IN 1961-62 IN POLAND].
    KULESZA A
    Przegl Epidemiol; 1964; 18():51-8. PubMed ID: 14189166
    [No Abstract]   [Full Text] [Related]  

  • 28. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 29. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
    Strebel PM; Aubert-Combiescu A; Ion-Nedelcu N; Biberi-Moroeanu S; Combiescu M; Sutter RW; Kew OM; Pallansch MA; Patriarca PA; Cochi SL
    Am J Epidemiol; 1994 Dec; 140(12):1111-24. PubMed ID: 7998593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of the eradication of indigenous wild poliomyelitis in the People's Republic of China.
    Wang Ka; Zhang LB; Otten MW; Zhang XL; Yasuo C; Zhang RZ; Xu T; Liu X; Liu M; Li QL; Yu JJ; Wang Z
    J Infect Dis; 1997 Feb; 175 Suppl 1():S105-12. PubMed ID: 9203701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A MASS VACCINATION CAMPAIGN AGAINST POLIOMYELITIS USING THE SABIN ORAL VACCINE.
    FRANKLIN GC; ROBERTSON MJ
    Public Health; 1965 Jan; 79():81-99. PubMed ID: 14251614
    [No Abstract]   [Full Text] [Related]  

  • 32. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 33. POLIOMYELITIS IN INDIA.
    SEN S
    J Indian Med Assoc; 1964 Aug; 43():192-4. PubMed ID: 14194425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental investigations on murine poliomyelitis virus in ticks (ornithodorus moubata)..].
    SCHULZ-EHLBECK HW
    Z Tropenmed Parasitol; 1952 May; 3(4):472-4. PubMed ID: 14959271
    [No Abstract]   [Full Text] [Related]  

  • 35. Poliomyelitis in the USA: virtual elimination of disease caused by wild virus.
    Kim-Farley RJ; Bart KJ; Schonberger LB; Orenstein WA; Nkowane BM; Hinman AR; Kew OM; Hatch MH; Kaplan JE
    Lancet; 1984 Dec; 2(8415):1315-7. PubMed ID: 6150330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SUCCESS OF PREVENTIVE VACCINATION AGAINST POLIOMYELITIS IN SWITZERLAND: ERADICATION OF POLIOMYELITIS?].
    GSELL O
    Schweiz Med Wochenschr; 1964 Mar; 94():382-5. PubMed ID: 14166100
    [No Abstract]   [Full Text] [Related]  

  • 37. Lessons from diagnostic investigations of patients with poliomyelitis and their direct contacts for the present surveillance of acute flaccid paralysis.
    Herremans T; Koopmans MP; van der Avoort HG; van Loon AM
    Clin Infect Dis; 1999 Oct; 29(4):849-54. PubMed ID: 10589902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [EXPERIMENTS ON VIRAL EXCRETION AND SERUM DIFFERENTIATION DURING A POLIOMYELITIS EPIDEMIC FOLLOWING ORAL VACCINATION WITH POLIOVIRUS TYPE-3].
    DEIBEL R; HORSTMANN W
    Klin Wochenschr; 1965 May; 43():570-3. PubMed ID: 14304400
    [No Abstract]   [Full Text] [Related]  

  • 39. Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis.
    Minor PD
    Expert Rev Mol Med; 1999 Sep; 1999():1-17. PubMed ID: 14585122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine.
    Salk D
    Rev Infect Dis; 1980; 2(2):243-57. PubMed ID: 6771867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.